| Antigen-specific vaccines for cancer treatment M Tagliamonte, A Petrizzo, ML Tornesello, FM Buonaguro, L Buonaguro Human vaccines & immunotherapeutics 10 (11), 3332-3346, 2014 | 186 | 2014 |
| Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses. L Buonaguro, ML Tornesello, M Tagliamonte, RC Gallo, LX Wang, ... J Virol 80 (18), 9134-9143, 2006 | 149 | 2006 |
| Developments in virus-like particle-based vaccines for infectious diseases and cancer L Buonaguro, M Tagliamonte, ML Tornesello, FM Buonaguro Expert review of vaccines 10 (11), 1569-1583, 2011 | 109 | 2011 |
| Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders L Fantuzzi, M Tagliamonte, MC Gauzzi, L Lopalco Cellular and molecular life sciences 76 (24), 4869-4886, 2019 | 106 | 2019 |
| Challenges in cancer vaccine development for hepatocellular carcinoma L Buonaguro, A Petrizzo, M Tagliamonte, ML Tornesello, FM Buonaguro Journal of hepatology 59 (4), 897-903, 2013 | 102 | 2013 |
| Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles … L Buonaguro, ML Visciano, ML Tornesello, M Tagliamonte, B Biryahwaho, ... J Virol 79 (11), 7059-7067, 2005 | 91 | 2005 |
| Effects of adjuvants on IgG subclasses elicited by virus-like particles ML Visciano, M Tagliamonte, ML Tornesello, FM Buonaguro, ... Journal of translational medicine 10, 1-9, 2012 | 89 | 2012 |
| Selecting target antigens for cancer vaccine development L Buonaguro, M Tagliamonte Vaccines 8 (4), 615, 2020 | 84 | 2020 |
| Immunotherapy in hepatocellular carcinoma L Buonaguro, A Mauriello, B Cavalluzzo, A Petrizzo, M Tagliamonte Annals of hepatology 18 (2), 291-297, 2019 | 80 | 2019 |
| SARS-CoV-2 RNA polymerase as target for antiviral therapy L Buonaguro, M Tagliamonte, ML Tornesello, FM Buonaguro Journal of Translational Medicine 18, 1-8, 2020 | 75 | 2020 |
| Combinatorial immunotherapy strategies for hepatocellular carcinoma M Tagliamonte, A Petrizzo, ML Tornesello, G Ciliberto, FM Buonaguro, ... Current opinion in immunology 39, 103-113, 2016 | 62 | 2016 |
| Nanoparticles to improve the efficacy of peptide-based cancer vaccines AL Tornesello, M Tagliamonte, ML Tornesello, FM Buonaguro, ... Cancers 12 (4), 1049, 2020 | 61 | 2020 |
| Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins. ML Visciano, L Diomede, M Tagliamonte, ML Tornesello, V Asti, ... Vaccine 29 (31), 4903-4912, 2011 | 56 | 2011 |
| Virus-like particles as preventive and therapeutic cancer vaccines AL Tornesello, M Tagliamonte, FM Buonaguro, ML Tornesello, ... Vaccines 10 (2), 227, 2022 | 48 | 2022 |
| Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation E Aricò, E Wang, ML Tornesello, M Tagliamonte, GK Lewis, FM Marincola, ... Journal of Translational Medicine 3, 1-14, 2005 | 48 | 2005 |
| Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran. HR Naderi, M Tagliamonte, ML Tornesello, M Ciccozzi, G Rezza, R Farid, ... Infect Agent Cancer 1, 4, 2006 | 46 | 2006 |
| Exploiting preexisting immunity to enhance oncolytic cancer immunotherapy S Tähtinen, S Feola, C Capasso, N Laustio, C Groeneveldt, EO Ylösmäki, ... Cancer Research 80 (12), 2575-2585, 2020 | 45 | 2020 |
| High somatic mutation and neoantigen burden do not correlate with decreased progression-free survival in HCC patients not undergoing immunotherapy A Mauriello, R Zeuli, B Cavalluzzo, A Petrizzo, ML Tornesello, ... Cancers 11 (12), 1824, 2019 | 42 | 2019 |
| Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model M Tagliamonte, A Petrizzo, M Napolitano, A Luciano, C Arra, P Maiolino, ... Cancer Immunology, Immunotherapy 64, 1305-1314, 2015 | 38 | 2015 |
| Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches M Tagliamonte, A Mauriello, B Cavalluzzo, C Ragone, C Manolio, ... Cancer Letters 473, 25-32, 2020 | 37 | 2020 |
